Jennifer Doudna (UC Berkeley Professor) – Fireside Chat at Innovative Genomics Institute (Aug 2020)


Chapters

00:00:00 IGI Fireside Chat: Transition and Leadership
00:05:28 Application of Scientific Research in Defense and Medicine
00:11:17 Vision for the Institute for Genomic Innovation
00:13:39 IGI Mission Statement: Affordable Genomics in Climate and Human Health
00:15:54 Unique Features and Mission of the Innovative Genomics Institute
00:20:25 Lab Mishaps and Personal Pursuits of Two Scientists
00:30:18 Unlikely Paths to a Career in Science
00:35:09 Enhancing Diversity and Inclusion in Scientific Research
00:39:56 Vision of Institute for Genetic Medicine's Societal Impact
00:49:23 IGI Financial Priorities Amidst the Pandemic and Plans for the Future

Abstract

Innovative Genomics Institute: Charting a New Course in Biotechnology and Sustainability

Embracing Change and Innovation at IGI: A Comprehensive Overview

In a significant gathering at the Innovative Genomics Institute (IGI), notable figures Jennifer Doudna and Brad Ringeisen led a comprehensive discussion outlining the future direction and vision of IGI. This article synthesizes the key points from the event, adopting an inverted pyramid style to emphasize the most crucial information upfront.

IGI Mission Statement: Driving Change in Health and Climate

IGI’s mission is to bridge revolutionary gene editing tool development to affordable and accessible solutions in climate and human health. The institute envisions a world where genomic technology is routinely applied to cure genetic diseases, enable sustainable agriculture, and achieve a carbon-neutral economy. Its focus on both genetic disease and climate change makes it distinctive, and its multidisciplinary approach incorporates chemistry, material science, protein chemistry, immunology, molecular biology, microbiology, and tool discovery.

Jennifer Doudna’s Welcome: A Grateful Beginning

Jennifer Doudna, a prominent figure in gene editing, opened the fireside chat by welcoming attendees and introducing Brad Ringeisen as the new executive director of IGI. Her opening remarks set a tone of gratitude, especially towards the IGI team for their dedication during the challenging COVID-19 pandemic. She acknowledged and thanked individuals like Andy, Megan, Clarice, Melanie Cantorudi, Christy, Yulia, Edward, Arianna, and Lucy for their contributions. Doudna also invited attendees to mute their lines and submit questions via the chat box.

Brad Ringeisen: A New Leader with a Rich Background

Brad Ringeisen, with a profound background from DARPA, was introduced as IGI’s new executive director. His extensive scientific knowledge and organizational skills were highlighted, emphasizing his crucial role in executing IGI’s strategic plan. Ringeisen’s diverse scientific background, ranging from cell printing and bioprinting to microbial fuel cells and extracellular electron transfer of bacteria, was elaborated upon.

He shared his career path, including working as a postdoc at the Naval Research Laboratory, where he conducted experiments on printing living mammalian cells and bacteria. He also led a section called biofabrication and bioenergy, focusing on cell printing and microbial fuel cells. Additionally, Ringeisen discussed his transition from bench research to program management roles, gaining experience outside of academia. He managed programs at the Defense Threat Reduction Agency and DARPA, focusing on field forward diagnostics, paper lateral flow diagnostics, synthetic biology, infectious disease research, and neurotechnology. His contributions at DARPA were also highlighted, such as overseeing investments in Moderna and Inovio vaccines, the chikungunya vaccine, antibody discovery, and antibody manufacture. Moreover, he led the Safe Genes program, emphasizing safety precautions for gene editing technologies. He also collaborated on the PREPARE and DIGIT programs, exploring transcriptional editing, epigenetic editing, and diagnostics development using gene editing.

As a child, Ringeisen demonstrated an exceptional talent in playing pool. He would often compete with professors at Clemson University during dinner parties hosted by his parents. His exceptional skill earned him recognition and admiration, and there are even pictures of him performing trick shots in pool at DARPA.

Jonathan Weissman and Jennifer Doudna: New Roles, Continued Influence

Jonathan Weissman’s move to the Whitehead Institute and his new role as chair of IGI’s scientific advisory board was noted. Similarly, Jennifer Doudna’s future role as chair of IGI’s governance board, focusing on strategy and fundraising, underlines the evolving leadership dynamics within the organization.

Ringeisen’s Opening Remarks: Enthusiasm for IGI’s Mission

Ringeisen expressed his enthusiasm for joining IGI and gratitude for the warm reception. His diverse scientific background, particularly in biofabrication and bioprinting, and his role in mRNA vaccine development, underscore his capability to lead IGI’s ambitious projects.

IGI’s People, Ideas, and Technologies: Driving Innovation

IGI’s strength lies in its exceptional people, their ideas, and technologies. The institute fosters an environment of challenge and ambition, aiming to use fundamental research and technology development equitably, addressing societal needs. IGI aims to break down traditional academic silos, fostering innovation and comprehensive solutions to complex problems. This collaborative spirit is crucial for the organization’s success.

Brad Ringeisen’s Vision: Accessible Biotechnology and Collaborative Research

Ringeisen’s vision for IGI revolves around making biotechnology and gene editing accessible to all. He emphasizes the importance of collaborative research and finding solutions to global challenges. Ringeisen believes that biotechnology and gene editing can serve as equalizing factors, making these technologies accessible to a wide range of individuals and not just a privileged few. His goal at IGI is to enable everyone to benefit from these advancements, ensuring that the benefits of biotechnology are not limited to the top individuals or organizations.

IGI’s Financial Footing:

Ensuring a strong financial basis for the Institute is a key challenge. The team has successfully raised funds during the pandemic for immediate needs. Raising money for specific projects and supporting core operations are important.

IGI’s Strategic Priorities:

The Institute aims to avoid spreading resources too thin and diffusing its efforts. Focusing on specific priorities and aligning projects with the Institute’s mission is crucial. The new development team will emphasize targeted funding rather than dispersing funds across numerous projects.

IGI’s Team Dynamics and Communication:

Having a dedicated and talented team is essential for the Institute’s success. The new leader emphasizes active listening, communication, and addressing concerns. The Institute encourages feedback and suggestions from its stakeholders. Adapting communication methods, such as virtual meetings, during challenging times is necessary. The goal is to maintain strong team dynamics and facilitate collaboration.

Personal Experiences and Mishaps: Learning from the Past

Both Doudna and Ringeisen shared personal experiences and lab incidents, highlighting the importance of safety and the human aspect of scientific work. Ringeisen’s childhood and hidden talent in pool, and Doudna’s formative years in Hawaii, offered insights into their personal journeys and passion for science.

IGI’s Societal Impact: Equity and Accessibility in Focus

IGI’s commitment to addressing societal, ethical, and economic aspects of biotechnology and genomics, promoting equity and accessibility, was a focal point. The institute seeks to ensure that economic factors do not limit access to drugs and therapies.

Financial Sustainability and Responsible Technology Development

The financial sustainability of IGI was discussed, with a focus on developing a robust model supporting both research and operational needs. Additionally, the responsible use of technology, particularly genome editing, was underscored.

Challenges and Opportunities Ahead for IGI

The challenges and opportunities IGI faces were candidly discussed, including fostering a bi-campus organization and ensuring financial stability. The institute’s commitment to open communication, engagement, and embracing virtual operations during the pandemic was also highlighted.

In summary, the fireside chat at IGI marked a pivotal moment in the institute’s trajectory, with a renewed focus on innovation, accessibility, and societal impact. Under the leadership of Jennifer Doudna and Brad Ringeisen, IGI is poised to make significant contributions in the fields of biotechnology and sustainability, bridging the gap between groundbreaking research and real-world applications.


Notes by: QuantumQuest